Clinical trial
A Single-center, Randomized, Double-blind, Comparator-controlled Parallel Study Investigating the Bioavailability of Cannabidiol and Δ9-Tetrahydrocannabinol in an Emulsion Product in a Healthy Population
NCT04601207 is registered in ClinicalTrials.gov with New Age Ventures LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-center, Randomized, Double-blind, Comparator-controlled Parallel Study Investigating the Bioavailability of Cannabidiol and Δ9-Tetrahydrocannabinol in an Emulsion Product in a Healthy Population
- Lead sponsor
- New Age Ventures LLC
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 19, 2020
- Completion date
- November 30, 2020
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis, healthy